Published online Apr 28, 2025. doi: 10.3748/wjg.v31.i16.102778
Revised: March 9, 2025
Accepted: March 17, 2025
Published online: April 28, 2025
Processing time: 180 Days and 19.2 Hours
In this editorial, we comment on the article by Teerasarntipan et al published in a recent issue of the World Journal of Gastroenterology. Dengue infection is a major mosquito-borne disease with global significance. Dengue-induced severe hepatitis (DISH) is a rare complication though severe, as it can lead to acute liver failure (ALF) with an incidence rate between 0.7% and 2.0% and mortality rates from 47.0% to 58.8%. In this context, the identification of patients at risk of ALF could improve prognosis in DISH patients. Teerasarntipan et al retrospectively enrolled 2532 dengue patients, counting 193 DISH and 20 ALF. The authors explored the prognostic role of liver-specific scores, as the model for end-stage liver disease (MELD) score, albumin-bilirubin (ALBI) score, easy (EZ)-ALBI score, and platelet-ALBI (PALBI) score. Univariate analysis identified international normalized ratio (INR), total bilirubin, albumin, and creatinine as independent laboratory factors associated with ALF, while age, gender, and liver comorbidities were not linked to in-hospital mortality. The presence of dengue shock syndrome significantly increased mortality, with an odds ratio (OR) of 28.05 (95%CI: 7.21-109.18, P < 0.001). High INR and low albumin were laboratory markers associated with death from DISH, with ORs of 5.83 (95%CI: 2.59-13.12, P < 0.001) and 0.15 (95%CI: 0.05-0.44, P < 0.001), respectively. Multivariate analysis confirmed that INR remained the only significant predictor of both ALF and death, with adjusted ORs of 19.54 (95%CI: 3.37-113.38, P < 0.001) and 3.86 (95%CI: 1.13-13.18, P = 0.031), respec
Core Tip: Although dengue infection can result in liver injury, it rarely manifests as dengue-induced severe hepatitis (DISH). Since DISH can rapidly progress to acute liver failure, it appears crucial to early identify patients at risk in order to improve medical care and prognosis. In this context, liver specific prognostic scores, as model for end-stage liver disease or easy-albumin-bilirubin, proved effective when combined.